297 filings
Page 5 of 15
4
buvv3mjl z3rspduw
4 Oct 23
Immunome / FRANKLYN G PRENDERGAST ownership change
5:28pm
8-K
720voi7 dak2x
4 Oct 23
Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies
6:56am
4
2wub9am
3 Oct 23
Immunome / MICHAEL RAPP ownership change
5:50pm
425
ftzcrbgqq
21 Sep 23
Business combination disclosure
4:03pm
8-K
r8qyf5
21 Sep 23
Other Events
4:01pm
EFFECT
18ewiunn2i
29 Aug 23
Notice of effectiveness
12:15am
424B3
bphu7
28 Aug 23
Prospectus supplement
9:10am
S-4/A
b2wq7xz995q77qkk
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
CORRESP
47alx4v ssf0byc5kz
25 Aug 23
Correspondence with SEC
12:00am
UPLOAD
0s7sk8
11 Aug 23
Letter from SEC
12:00am
8-K
b92yd8wwr2wkuid
9 Aug 23
Immunome Reports Second Quarter 2023 Financial Results
8:27am
S-4
k0wgv5uaoyxsj xl7u
8 Aug 23
Registration of securities issued in business combination transactions
4:07pm
SC 13D
tmhqc8neaj 5ka
7 Jul 23
Immunome / MorphImmune ownership change
8:39am
425
ka01pyhzvnalwc5 yh
5 Jul 23
Business combination disclosure
5:15pm
8-K
vw1wb ruv0sad
5 Jul 23
Morphimmune and Immunome Combined Corporate Presentation July 2023
5:12pm
425
oqi4h
29 Jun 23
Business combination disclosure
4:45pm
425
ub9au3ev
29 Jun 23
Business combination disclosure
9:10am
8-K
lha1qjh xwzy0
29 Jun 23
Immunome and Morphimmune Announce Definitive Merger Agreement
9:08am
8-K
1ep5khkvi
13 Jun 23
Submission of Matters to a Vote of Security Holders
5:00pm